2016
DOI: 10.1016/j.bjane.2015.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness of dexmedetomidine for emergence agitation in infants undergoing palatoplasty: a randomized controlled trial

Abstract: Dex administration has the advantage of a reduced EA and PS without any adverse effects. Dex provided satisfactory recovery in infants undergoing palatoplasty.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
12
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(14 citation statements)
references
References 33 publications
(31 reference statements)
2
12
0
Order By: Relevance
“…Confirming the previous trials,[1171819] this trial emphasized that dexmedetomidine markedly decreases the incidence of EA and curtail its severity in children after sevoflurane anesthesia without complications and with smooth postoperative recovery course.…”
Section: Discussionsupporting
confidence: 82%
“…Confirming the previous trials,[1171819] this trial emphasized that dexmedetomidine markedly decreases the incidence of EA and curtail its severity in children after sevoflurane anesthesia without complications and with smooth postoperative recovery course.…”
Section: Discussionsupporting
confidence: 82%
“…Boku and colleagues found similar results in 70 infants aged 10 to 14 months undergoing cleft palate surgery, where infants either received dexmedetomidine or saline during sevoflurane anesthesia. Based on an anesthesiologist's score of emergence agitation and pain, agitation and pain were found to be significantly lower in children who were given dexmedetomidine as compared to those given saline (Boku et al, 2016 (Lehmkuhl et al, 1987). Similar results were found in a group of middle-aged adults who received isoflurane and fentanyl anesthesia during abdominal surgery.…”
Section: Negative Postoperative Behavioural Changessupporting
confidence: 53%
“…Prophylactic pharmaceutical interventions such as α 2 -agonist [5][6][7], µ-opioid agonists [8][9], and propofol [10] are effective for preventing EA. Dexmedetomidine, a selective α 2 -adrenoceptor agonist, significantly reduced the incidence of EA in children [11,12].…”
Section: Introductionmentioning
confidence: 99%